Bolden Announces $1.5M Pre-Seed Financing

Development of Antisense Oligonucleotides Seeks to Promote Neurogenesis…


MindImmune Appoints Industry Leaders to Board of Directors

Brad Margus and Robert Michael Poole, MD FACP, bring deep background and…


Rhode Island Commerce Awards Slater $12M for Venture Development

VC Firm Receives SSBCI Funding for Second Time Providence, R.I. –  In…


Slater Invests in XM Therapeutics from Brown University

Biotech Targeting Heart Failure and Pulmonary Fibrosis Comes out of Stealth…


RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company

New Fund Participates in Series A Financing for URI-Based MindImmune, Developer…


Arctura Awarded $1.15 Million Grant from U.S. Dept. of Energy

SBIR Phase IIB Grant Will Enable Arctura to Field Test Its Proprietary…


Slater-Backed Company Acquired by Novartis

Former Drug Development Firm, Founded in Rhode Island in 2010, is Part of…